Mark N. Lampert, 10% Owner at ChemoCentryx, Inc. (CCXI), bought 40,000 shares at $12.00 ($480K) on 2012-11-06, disclosed to the SEC on 2012-11-08.
Open-market purchase of $480k CCXI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |